Mounjaro users issued price warning ahead of 170 per cent spike

An NHS-backed weight-loss programme has announced it will freeze the cost of its Mounjaro programme for existing customers this September, despite the drug’s manufacturer imposing price hikes of up to 170 per cent. Second Nature , which offers two medication-assisted plans, said the move is designed to protect patients from “abrupt treatment disruption” while the market recalibrates.

The announcement comes after Eli Lilly confirmed that from 1 September, prices for Mounjaro - a weekly injectable weight-loss medicine increasingly prescribed for obesity and type 2 diabetes - would rise steeply across all doses. Chris Edson, CEO and co-founder of Second Nature, said many patients on private programmes will now face difficult

See Full Page